The 22G Trident Needle Combined With Different Aspiration Techniques for Endoscopic Ultrasound-guided Fine-needle Biopsy
NCT ID: NCT07023562
Last Updated: 2025-06-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
270 participants
INTERVENTIONAL
2025-06-25
2027-05-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The 22G Franseen Needle Combined With Different Aspiration Techniques for Endoscopic Ultrasound-guided Fine-needle Biopsy
NCT07023549
Impact of Suction in the EUS-guided Fine Needle Biopsy of Solid Pancreatic Lesions
NCT04164017
22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions
NCT06563232
Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions
NCT01936467
Fine-needle Biopsy Combined With Macroscopic On-site Evaluation for Diagnosis of Solid Pancreatic Lesions
NCT06994611
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ABC group
ABC suction sequence
Suction sampling should be conducted in the sequence of dry-suction, slow-pull and wet-suction.
ACB group
ACB suction sequence
Suction sampling should be conducted in the sequence of dry-suction, wet-suction and slow-pull.
BAC group
BAC suction sequence
Suction sampling should be conducted in the sequence of slow-pull, dry-suction and wet-suction.
BCA group
BCA suction sequence
Suction sampling should be conducted in the sequence of slow-pull, wet-suction and dry-suction.
CAB group
CAB suction sequence
Suction sampling should be conducted in the sequence of wet-suction, dry-suction and slow-pull.
CBA group
CBA suction sequence
Suction sampling should be conducted in the sequence of wet-suction, slow-pull and dry-suction.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ABC suction sequence
Suction sampling should be conducted in the sequence of dry-suction, slow-pull and wet-suction.
ACB suction sequence
Suction sampling should be conducted in the sequence of dry-suction, wet-suction and slow-pull.
BAC suction sequence
Suction sampling should be conducted in the sequence of slow-pull, dry-suction and wet-suction.
BCA suction sequence
Suction sampling should be conducted in the sequence of slow-pull, wet-suction and dry-suction.
CAB suction sequence
Suction sampling should be conducted in the sequence of wet-suction, dry-suction and slow-pull.
CBA suction sequence
Suction sampling should be conducted in the sequence of wet-suction, slow-pull and dry-suction.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. 18-80 years old (inclusive), male and female;
2. patients with pancreatic solid mass \> 1cm detected by CT/MRI/PET-CT or EUS and requiring EUS-FNB diagnosis.
3. written informed consent was obtained.
Exclusion Criteria
1. contraindications to endoscopy, such as severe cardiovascular and cerebrovascular diseases;
2. bleeding coagulation dysfunction (prothrombin international normalized ratio ≥1.5, platelet count ≤ 50 000) or use of antiplatelet drugs;
3. confirmed pregnancy or possible pregnancy;
4. pathological diagnosis has been obtained by other methods;
5. refuse to participate in the study, are participating in another observational clinical trial, or have participated in another clinical trial within 60 days.
6. other situations where EUS-FNB could not be performed.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Changhai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhaoshen Li
Department of Gastroenterology, Changhai Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhao Shen Li, M.D
Role: PRINCIPAL_INVESTIGATOR
Department of Gastroenterology, Changhai Hospital, Naval Medical University (Second Military Medical University), shanghai, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Changhai Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KTSB20250423035
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.